Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Clinical Study on the Safety and Efficacy of CD19-Targeted Universal CAR-γδ T Cells in Relapsed/Refractory Autoimmune Nephropathy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07535138
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:09.507815+00:00
Published At
2026-04-16T00:00:00+00:00
Record Updated At
2026-04-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Membranous Nephropathy", "Lupus Nephritis (LN)", "IgA Nephropathy (IgAN)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-16"
protocolSection.identificationModule.nctId
"NCT07535138"
protocolSection.identificationModule.officialTitle
"A Clinical Study on the Safety and Efficacy of CD19-Targeted Universal CAR-\u03b3\u03b4 T Cells in Relapsed/Refractory Autoimmune Nephropathy"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Membranous Nephropathy (protocolSection.conditionsModule.conditions)
  • Lupus Nephritis (LN) (protocolSection.conditionsModule.conditions)
  • IgA Nephropathy (IgAN) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.